Skin Cancer PreventionNCT07681791
Sun Safe Together: A Digital Skin Cancer Prevention Intervention for Adolescents and Their Parents
A study testing Teen MMS and Parent Facebook in people with Skin Cancer Prevention, run by Rutgers, The State University of New Jersey at 1 site in United States.
Trial summary
The goal of this pilot clinical trial is to learn if a digital intervention to improve sun safety, Sun Safe Together (SST), is feasible and acceptable to teenagers and their parents. Read more about this study
- Who is it for?
- Ages 13 years and olderHealthy volunteers can take part
- Conditions the study is for
- Skin Cancer Prevention
- What is being tested?
- Teen MMS and Parent Facebook
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 104 participants
- Where
- 1 siteUnited States
- Study dates
- Aug 2026to Dec 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 13 years and older
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- Parents and teens are participating as dyads, meaning both the parent and the teen need to be deemed eligible based on the criteria below to be able to participate.
- Teens
- Must be ages 13-17 years
- Live with study parent equal to or greater than half time in US
- Have experienced sunburn or indoor tanned in the last year or have a suboptimal sun protection score
- Have no personal history of melanoma or severe medical condition that prevents participation
Show all 16Show fewer
- Have access to smartphone
- Speak and read English
- Parents/Guardians
- Must be age 18 or older
- Live with a teen equal to or greater than half time in US
- Have a teen who had experienced sunburn or indoor tanned in the last year or have a suboptimal sun protection score
- Have no personal history of melanoma or severe medical condition that prevents participation
- Have internet at home, a Facebook account, and be willing to use Facebook daily
- Have access to smartphone
- Speak and read English
Who cannot join
None listed.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
Rutgers Cancer Institute
New Brunswick, New Jersey, 08901
Anna Mitarotondo, MS, 732-514-2891, atm122@cinj.rutgers.edu
Carolyn J. Heckman, PhD, teenhealthstudy@cinj.rutgers.edu
About this study
Official title: A Digital Skin Cancer Prevention Intervention for Adolescents and Their Parents
The goal of this pilot clinical trial is to learn if a digital intervention to improve sun safety, Sun Safe Together (SST), is feasible and acceptable to teenagers and their parents.
Read the detailed description
Melanoma is a leading cause of invasive cancer in teens and young adults aged 15-39. Most skin cancers are preventable with skin protection such as minimizing UVR exposure and wearing protective clothing and sunscreen. However, teens have low levels of sun protection. Thus, interventions targeting skin cancer risk reduction among teens are needed. The proposed Sun Safe Together (SST) intervention is a 12-week program consisting of sun safety and general health messages sent via multimedia messaging service (MMS) to teens and via a private Facebook group for parents.
This pilot trial is a single arm test of SST to determine:
- feasibility of enrolling parent-teen dyads
- engagement with/acceptability of the intervention via message views and acceptability ratings
- outcome data collection feasibility (i.e., daily diary, UVR exposure measured by UVR dosimeter)
- retention rates for teens and parents at 3 and 6 months
- Conditions
- Skin Cancer Prevention
- Being tested
- Teen MMS, Parent Facebook
- Keywords
- Sun Safety, Teens, Messages, Teen health, Parents, Education
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Teen MMSBehavioural
Teens will receive MMS messages regarding sun safety behaviors and other general health issues for 12 weeks.
Parent FacebookBehavioural
Parents of teenagers join a private Facebook group where membership, activities, and content are only viewable by invited members. Content related to teen sun safety and general health will be posted for 12 weeks. Research staff will moderate the group.
| Study group | Role | What they receive |
|---|---|---|
| Teen MMS & Parent Facebook Intervention | Experimental | Not described Receives: Behavioral: Teen MMS; Behavioral: Parent Facebook |
What is being measured
The primary outcome is the main question the study is designed to answer.
Feasibility of recruitment
Feasibility of recruitment will be assessed by the proportion of eligible parent-teen dyads that enroll in the study
Measured: Baseline
Acceptability of MMS intervention
Items were adapted from the Acceptability of Intervention and Feasibility of Intervention Measures to obtain participant feedback about the acceptability, feasibility, ease of use, and impact of the intervention. Individual items are rated on a 5-point likert scale from (1) Completely Disagree to (5) Completely Agree. Higher scores indicated greater acceptability.
Measured: Immediately after the intervention
Engagement with MMS intervention
Proportion of messages viewed will be calculated to describe engagement.
Measured: 3-months
Feasibility of Outcome Data Collection - 7-Day Diaries
Proportion of teens who complete 7-day diaries will be calculated.
Measured: Baseline, 3-months, 6-months
Feasibility of Outcome Data Collection - UVR Dosimeter
Proportion of teens who return UVR dosimeter with usable data will be calculated.
Measured: Baseline, 6 months
Retention
Proportion of enrolled teens who complete surveys at 3- and 6-months will be calculated.
Measured: 3-months, 6-months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Jul 2026
- Study startAug 2026 (estimated)
- Primary completionDec 2027 (estimated)
- Study completionDec 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Skin Cancer PreventionStudies of the same condition, open and under way.
- More trials run by Rutgers, The State University of New JerseyThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- Teens and their parents (dyads) will get similar but separate interventions simultaneously.
- Masking
- None (open label)
- Enrolment
- 104 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Rutgers, The State University of New Jersey
- Sponsor type
- University, hospital or other
- Collaborators
- National Cancer Institute (NCI)
- Responsible party
- Principal investigator, Dr. Carolyn Heckman, Ph.D, Rutgers, The State University of New Jersey
- Investigators
- Carolyn Heckman, PhD, Principal investigator, Rutgers, The State University of New JerseyKatie A Devine, PhD, Principal investigator, Rutgers, The State University of New Jersey
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07681791
- Sponsor's protocol ID
- Pro2025001264
- Other IDs
- R34CA293237
- Status last verified
- Aug 2026
- First submitted
- 25 Jun 2026
- Last updated
- 5 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: De-identified study data and associated documentation will be made available to the research community through the Data Sharing for Demographic Research (DSDR) data repository hosted at the Inter-university Consortium for Political and Social Research (ICPSR).
Study at a glance
From the registry record, last updated by the sponsor on 5 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Digital Skin Cancer Prevention Intervention for Adolescents and Their Parents
- ClinicalTrials.gov ID
- NCT07681791
- Acronym / sponsor ID
- Pro2025001264
- Conditions
- Skin Cancer Prevention
- Keywords
- Sun Safety, Teens, Messages, Teen health, Parents, Education
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 104 participants (estimated)
- Lead sponsor
- Rutgers, The State University of New JerseyUniversity, hospital or other
- Collaborators
- National Cancer Institute (NCI)
- Study start
- Aug 2026 (estimated)
- Primary completion
- Dec 2027 (estimated)
- Study completion
- Dec 2027 (estimated)
- First posted
- 2 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this pilot clinical trial is to learn if a digital intervention to improve sun safety, Sun Safe Together (SST), is feasible and acceptable to teenagers and their parents.
Detailed description
Melanoma is a leading cause of invasive cancer in teens and young adults aged 15-39. Most skin cancers are preventable with skin protection such as minimizing UVR exposure and wearing protective clothing and sunscreen. However, teens have low levels of sun protection. Thus, interventions targeting skin cancer risk reduction among teens are needed. The proposed Sun Safe Together (SST) intervention is a 12-week program consisting of sun safety and general health messages sent via multimedia messaging service (MMS) to teens and via a private Facebook group for parents.
This pilot trial is a single arm test of SST to determine:
- feasibility of enrolling parent-teen dyads
- engagement with/acceptability of the intervention via message views and acceptability ratings
- outcome data collection feasibility (i.e., daily diary, UVR exposure measured by UVR dosimeter)
- retention rates for teens and parents at 3 and 6 months
Study design
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- Teens and their parents (dyads) will get similar but separate interventions simultaneously.
| Arm | Type | Receives |
|---|---|---|
| Teen MMS & Parent Facebook Intervention | Experimental | Behavioral: Teen MMS, Behavioral: Parent Facebook |
Who may qualify
- Ages
- 13 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (16 listed)
- Parents and teens are participating as dyads, meaning both the parent and the teen need to be deemed eligible based on the criteria below to be able to participate.
- Teens
- Must be ages 13-17 years
- Live with study parent equal to or greater than half time in US
- Have experienced sunburn or indoor tanned in the last year or have a suboptimal sun protection score
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Teen MMSTeens will receive MMS messages regarding sun safety behaviors and other general health issues for 12 weeks. | Behavioural | Teen MMS & Parent Facebook Intervention |
| Parent FacebookParents of teenagers join a private Facebook group where membership, activities, and content are only viewable by invited members. Content related to teen sun safety and general health will be posted for 12 weeks. Research staff will moderate the group. | Behavioural | Teen MMS & Parent Facebook Intervention |
Primary outcome
Feasibility of recruitment
Time frame: Baseline
Feasibility of recruitment will be assessed by the proportion of eligible parent-teen dyads that enroll in the study
Acceptability of MMS intervention
Time frame: Immediately after the intervention
Items were adapted from the Acceptability of Intervention and Feasibility of Intervention Measures to obtain participant feedback about the acceptability, feasibility, ease of use, and impact of the intervention. Individual items are rated on a 5-point likert scale from (1) Completely Disagree to (5) Completely Agree. Higher scores indicated greater acceptability.
Engagement with MMS intervention
Time frame: 3-months
Proportion of messages viewed will be calculated to describe engagement.
Feasibility of Outcome Data Collection - 7-Day Diaries
Time frame: Baseline, 3-months, 6-months
Proportion of teens who complete 7-day diaries will be calculated.
Feasibility of Outcome Data Collection - UVR Dosimeter
Time frame: Baseline, 6 months
Proportion of teens who return UVR dosimeter with usable data will be calculated.
Retention
Time frame: 3-months, 6-months
Proportion of enrolled teens who complete surveys at 3- and 6-months will be calculated.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Aug 2026.
- Individual participant dataSharing planned: Yes. De-identified study data and associated documentation will be made available to the research community through the Data Sharing for Demographic Research (DSDR) data repository hosted at the Inter-university Consortium for Political and Social Research (ICPSR).
Related trials for Skin Cancer Prevention
Not yet recruitingPhase 2
Netupitant/Palonosetron for Prevention of Nausea and Vomiting in Breast Cancer ADC Therapy
Breast Cancer
RecruitingPhase 2
A Study of Different Skin Care Approaches to Prevent Skin Reactions in People With Breast Cancer Receiving Radiation Therapy After Mastectomy
Breast Cancer, Breast Cancer Female
Not yet recruitingObservational study
An Overview of Vaccination Coverage Among Patients Receiving Treatment for Breast Cancer at the ICO: Identifying Factors Associated With Vaccination Uptake and Improved Prevention
Breast Cancer
Recruiting
Early Detection of Skin Tumors Using a Telemedicine Tool in Primary Care
Skin Cancer Prevention, Melanoma In Situ
Not yet recruiting
Continuous Controlled Cooling for Prevention of Chemotherapy-Induced Peripheral Neuropathy
Chemotherapy Induced Peripheral Neuropathy (CIPN)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Carolyn Heckman, PhD principal investigator
Rutgers, The State University of New Jersey
Katie A Devine, PhD principal investigator
Rutgers, The State University of New Jersey
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Teen MMS and Parent Facebook in people with Skin Cancer Prevention, run by Rutgers, The State University of New Jersey at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 16 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 5 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Feasibility of recruitment (time frame: Baseline). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Aug 2026.